Article Text

Download PDFPDF

Correction: Did Philip Morris International use the e-cigarette, or vaping, product use associated lung injury (EVALI) outbreak to market IQOS heated tobacco?
Free

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Ayers JW, Leas EC, Dredze M, et al. Did Philip Morris International use the e-cigarette, or vaping, product use associated lung injury (EVALI) outbreak to market IQOS heated tobacco? Tobacco Control Published Online First: 16 April 2021. doi: 10.1136/tobaccocontrol-2021-056661

This article has been corrected since publication to address points raised to BMJ and in the rapid responses.

The language of title and text of the article has been amended to be clear that causal claims cannot be made, in keeping with the work that the authors have done.

Regarding replication and transparency, the analysis was performed on a publicly accessible database that anyone can replicate https://tobaccowatcher.globaltobaccocontrol.org/. The authors must abide by the data sharing principles of the publishers and data aggregators. The full results are available on tobacco watcher but cannot be published as part of this article. The editorial team of the Tobacco Control journal are satisfied that the live Tobacco Watcher tool replicates the pattern of results described by the authors. The paper has been corrected to clarify this. The description of a key document from PMI has also been amended to read “public statement” throughout the main text at PMI’s request.